BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33789375)

  • 1. [Application of transcriptome sequencing and fusion genes analysis in the diagnosis of myeloid leukemia with normal karyotype].
    Jiang M; Zhou YR; Zhan Y; Zhang HQ; Zhang Q; Guo Y; Zhang ZL
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):939-944. PubMed ID: 33789375
    [No Abstract]   [Full Text] [Related]  

  • 2. A rare e13a3 (b2a3) BCR-ABL1 fusion transcript with normal karyotype in chronic myeloid leukemia: The challenges in diagnosis and monitoring minimal residual disease (MRD).
    Duan MH; Li H; Cai H
    Leuk Res; 2017 Aug; 59():8-11. PubMed ID: 28527402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic, fluorescence in situ hybridization, and genomic array characterization of chronic myeloid leukemia with cryptic BCR-ABL1 fusions.
    Shao L; Miller S; Keller-Ramey J; Zhang Y; Roulston D
    Cancer Genet; 2015; 208(7-8):396-403. PubMed ID: 26186983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients.
    Akhter A; Mughal MK; Elyamany G; Sinclair G; Azma RZ; Masir N; Shuib S; Rashid-Kolvear F; Shabani-Rad MT; Stewart DA; Mansoor A
    Diagn Pathol; 2016 Sep; 11(1):89. PubMed ID: 27632978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location of the BCR/ABL fusion genes on both chromosomes 9q34 in Ph negative chronic myeloid leukemia.
    Michalová K; Zemanová Z; Bkezinová J; Moravcová J; Oltová A; Sobotka J; Kuglík P; Kozak T; Sindelarová L; Jankovská M; Obomilová A; Sieglová Z; Polák J; Nádvorníková S; Haskovec C
    Leuk Lymphoma; 2002 Aug; 43(8):1695-700. PubMed ID: 12400616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
    Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
    Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid diagnosis of acute promyelocytic leukemia with the PML-RARA fusion gene using a combination of droplet-reverse transcription-polymerase chain reaction and instant-quality fluorescence in situ hybridization.
    Shigeto S; Matsuda K; Yamaguchi A; Sueki A; Uehara M; Sugano M; Uehara T; Honda T
    Clin Chim Acta; 2016 Jan; 453():38-41. PubMed ID: 26656442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray, gene sequencing, and reverse transcriptase-polymerase chain reaction analyses of a cryptic PML-RARA translocation.
    Koshy J; Qian YW; Bhagwath G; Willis M; Kelley TW; Papenhausen P
    Cancer Genet; 2012 Oct; 205(10):537-40. PubMed ID: 22982005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
    Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
    Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of fusion genes associated with specific translocations in acute leukemia patients with normal karyotypes by using multiplex RT-PCR].
    Ma L; Xue YQ; Pan JL; He J; Wu YF; Cen JN; Wen BZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):228-31. PubMed ID: 16638186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay.
    Brown J; Jawad M; Twigg SR; Saracoglu K; Sauerbrey A; Thomas AE; Eils R; Harbott J; Kearney L
    Blood; 2002 Apr; 99(7):2526-31. PubMed ID: 11895789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using an in situ RT-PCR assay.
    Preudhomme C; Chams-Eddine L; Roumier C; Duflos-Grardel N; Denis C; Cosson A; Fenaux P
    Leukemia; 1999 May; 13(5):818-23. PubMed ID: 10374889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of mate-pair sequencing to characterize a complex cryptic BCR/ABL1 rearrangement observed in a newly diagnosed case of chronic myeloid leukemia.
    Peterson JF; Pitel BA; Smoley SA; Smadbeck JB; Johnson SH; Vasmatzis G; Kearney HM; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP
    Hum Pathol; 2019 Jul; 89():109-114. PubMed ID: 30267776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic, fluorescence in situ hybridization, and molecular characterization of chronic myeloid leukemia in chronic phase with four BCR/ABL1 fusion signals: a case report.
    Vargas MT; Portero MA; Rodríguez A; Reyes J; Fernández-Novoa C
    Cancer Genet Cytogenet; 2009 Nov; 195(1):71-4. PubMed ID: 19837272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of leukemias with ETV6-ABL1 fusion.
    Zaliova M; Moorman AV; Cazzaniga G; Stanulla M; Harvey RC; Roberts KG; Heatley SL; Loh ML; Konopleva M; Chen IM; Zimmermannova O; Schwab C; Smith O; Mozziconacci MJ; Chabannon C; Kim M; Frederik Falkenburg JH; Norton A; Marshall K; Haas OA; Starkova J; Stuchly J; Hunger SP; White D; Mullighan CG; Willman CL; Stary J; Trka J; Zuna J
    Haematologica; 2016 Sep; 101(9):1082-93. PubMed ID: 27229714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of PML/RARalpha gene rearrangement in suspected acute promyelocytic leukemia patients using dual-color fluorescence in situ hybridization on bone marrow smears].
    Zhu YL; Wu YF; Pan JL; Xue YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):757-60. PubMed ID: 15631655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel, non-nested reverse-transcriptase polymerase chain reaction (RT-PCR) test for the detection of the t(15;17) translocation: a comparative study of RT-PCR cytogenetics, and fluorescence In situ hybridization.
    Rennert H; Golde T; Wilson RB; Spitalnik SL; Van Deerlin VM; Leonard DG
    Mol Diagn; 1999 Sep; 4(3):195-209. PubMed ID: 10553020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
    Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
    Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic, fluorescent in situ hybridization & reverse transcriptase-polymerase chain reaction analysis in acute promyelocytic leukaemia patients.
    Shivakumar S; Poonkhuzhali B; Gunasekaran S; Srivastava A; Chandy M
    Indian J Med Res; 2002 Feb; 115():59-67. PubMed ID: 12138666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUP98 is fused to topoisomerase (DNA) IIbeta 180 kDa (TOP2B) in a patient with acute myeloid leukemia with a new t(3;11)(p24;p15).
    Nebral K; Schmidt HH; Haas OA; Strehl S
    Clin Cancer Res; 2005 Sep; 11(18):6489-94. PubMed ID: 16166424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.